← FDA Drug Approvals (Drugs@FDA)
DOCETAXEL
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2023-02-28
Drug application
- FDA Application #
ANDA215744- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DOCETAXEL
- Generic name
- DOCETAXEL
- Active ingredients
- DOCETAXEL
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- ALEMBIC
- Manufacturer
- Baxter Healthcare Corporation
- First approval
- 2023-02-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown